“Golden root” or “Arctic root” (Rhodiola rosea) has attracted growing attention in both clinical and performance nutrition settings due to its proposed adaptogenic properties [1–3]. Adaptogens are compounds that help the body maintain homeostasis under physical, psychological, or environmental stress [4,5].
In Asia and Europe, Rhodiola species have long been used as adaptogens, tonics, antidepressants, and calming medicines or functional foods [2,5–7]. Much of Rhodiola’s biological activity is attributed to two major classes of phytochemicals - salidroside and rosavins [6,8]. While these compounds are frequently discussed together and are often standardized on supplement labels, they are chemically distinct, originate from different biosynthetic pathways, and may exert overlapping — but non-identical — physiological effects. Understanding their differences is vital for interpreting research, evaluating supplement quality, and designing targeted interventions.
In this article, we will take a look at what salidroside is, what rosavins are, and how they differ in terms of chemistry, pharmacology, and practical relevance.
What Is Salidroside?
Salidroside (also known as rhodioloside) is a phenolic compound found and extracted from Rhodiola plants. Compared with other adaptogens in traditional medicine, salidroside is suggested to possess unique value for addressing hypoxia, oxidative stress, and inflammation [1].
Salidroside can directly stimulate the production of erythropoietin (a hormone that increases red blood cell production in the bone marrow) and thereby improve the oxygen-carrying capacity of the blood [1].
While the content of natural salidroside in Rhodiola is only 0.5 – 0.8%, its production using chemical synthesis and biotechnology has become an area of interest for research and development [1,9].
Preclinical and clinical research indicates that salidroside may modulate the stress response through pathways such as the HPA axis, enhance mitochondrial function and cellular energy metabolism, and provide neuroprotective [10,11], pro-cognitive, and antioxidant effects. It has been used and poses important application value for the military, aerospace, and healthcare sectors.
What Are Rosavins?
The term “rosavins” refers not to a single compound but to several structurally related phenylpropanoid glycosides, comprising rosavin, rosin, and rosarin. These compounds are derived from cinnamyl alcohol and belong to the phenylpropanoid class of plant metabolites [12,13].
Rosavins have been associated with anti-fatigue and endurance-promoting effects, stress resilience, and mood regulation [14,15], as well as modulation of central nervous system activity [16]. Some evidence suggests rosavins may contribute more strongly to adaptogenic and anti-fatigue effects, particularly in exercise or stress-performance settings [14,17,18].
Why is the Ratio Important?
One of the most important distinctions between salidroside and rosavins is not just their individual effects but their ratio within the plant itself. In natural Rhodiola rosea root, the ratio is 1:3 [14]. This ratio has been adopted to commonly assess the authenticity and quality of extracts [8,19]. It also helps distinguish Rhodiola rosea from other species and reflects the natural phytochemical balance of the plant.
What are the Core Differences Between Salidroside and Rosavins?
While salidroside constitutes a small, simple phenylethanoid glycoside, rosavins are larger, more complex phenylpropanoid glycosides. This structural difference influences solubility, metabolism, and potentially pharmacokinetics of each compound.
Perhaps the most practical distinction is that salidroside is found across many Rhodiola species, but rosavins are unique to Rhodiola rosea [20].
The smaller structure of salidroside may allow faster absorption and more direct systemic effects, whereas the larger rosavins might undergo more extensive metabolism. With that said, comparative human pharmacokinetic data are still limited.
Do They Work Better Together?
A key question is whether salidroside and rosavins act independently or synergistically.
The prevailing view is that Rhodiola’s effects arise from a multi-compound synergy [14], not a single “active ingredient.” This aligns with traditional herbal use, whole-extract clinical trials, and tracks with the pharmacological complexity of adaptogens.
What are the Practical Implications?
Whole Rhodiola rosea extracts likely better reflect the combined effects of both compounds, whereas isolated salidroside may act through narrower mechanisms [21].
It should also be noted that not all “Rhodiola” is created equal. Rhodiola rosea contains both rosavins and salidroside, whereas Rhodiola crenulata typically contains salidroside but not rosavins [20].
A recent study found that nearly 60% of dietary supplements claiming to contain Rhodiola rosea did not contain the declared amount of roots or characteristic marker compounds associated with the species [22]. Rosavin was detected in only 9 of the 13 items analyzed, with four of these containing only trace amounts.
Likewise, a separate study found that approximately one-fifth of commercial products claiming to contain Rhodiola rosea did not contain rosavin, and some products appeared not to contain salidroside [23].
What about the Limitations of the Current Evidence?
Despite growing interest in both compounds, several gaps remain in the literature. For example, there are limited head-to-head human trials comparing salidroside with rosavins. There is also poor standardization across studies and substantial variability in extract composition [8,13,24]. As a result, many claims about their “distinct roles” are still partly inferential rather than definitively proven.
Conclusion
Salidroside and rosavins are two cornerstone phytochemical groups in Rhodiola rosea, but they differ in meaningful ways. Salidroside is a widely distributed, smaller phenylethanoid glycoside associated with neuroprotective, metabolic, and cognitive effects. Rosavins are a unique group of phenylpropanoid glycosides found only in Rhodiola rosea and are often linked to anti-fatigue and adaptogenic properties.
Perhaps most importantly, they coexist in a natural ~3:1 ratio, and much of Rhodiola’s efficacy likely depends on this balance rather than any single specific compound.
References
[1] K. Liang, S. Ma, K. Luo, R. Wang, C. Xiao, X. Zhang, Y. Gao, M. Li, Salidroside: An Overview of Its Promising Potential and Diverse Applications, Pharmaceuticals 17 (2024) 1703. https://doi.org/10.3390/
[2] H. Tao, X. Wu, J. Cao, Y. Peng, A. Wang, J. Pei, J. Xiao, S. Wang, Y. Wang, Rhodiola species: A comprehensive review of traditional use, phytochemistry, pharmacology, toxicity, and clinical study, Medicinal Research Reviews 39 (2019) 1779–1850. https://doi.org/10.1002/med.
[3] F. Iannuzzo, E. Schiano, A. Pastore, F. Guerra, G.C. Tenore, E. Novellino, M. Stornaiuolo, Controlled Cultivation Confers Rhodiola rosea Synergistic Activity on Muscle Cell Homeostasis, Metabolism and Antioxidant Defense in Primary Human Myoblasts, Antioxidants 13 (2024) 1000. https://doi.org/10.3390/
[4] L. Liao, Y. He, L. Li, H. Meng, Y. Dong, F. Yi, P. Xiao, A preliminary review of studies on adaptogens: comparison of their bioactivity in TCM with that of ginseng-like herbs used worldwide, Chin Med 13 (2018) 57. https://doi.org/10.1186/
[5] O. Kosakowska, K. Bączek, J.L. Przybył, E. Pióro-Jabrucka, W. Czupa, A. Synowiec, M. Gniewosz, R. Costa, L. Mondello, Z. Węglarz, Antioxidant and Antibacterial Activity of Roseroot (Rhodiola rosea L.) Dry Extracts, Molecules 23 (2018) 1767. https://doi.org/10.3390/
[6] A. Panossian, G. Wikman, J. Sarris, Rosenroot (Rhodiola rosea): Traditional use, chemical composition, pharmacology and clinical efficacy, Phytomedicine 17 (2010) 481–493. https://doi.org/10.1016/j.
[7] W. Pu, M. Zhang, R. Bai, L. Sun, W. Li, Y. Yu, Y. Zhang, L. Song, Z. Wang, Y. Peng, H. Shi, K. Zhou, T. Li, Anti-inflammatory effects of Rhodiola rosea L.: A review, Biomedicine & Pharmacotherapy 121 (2020) 109552. https://doi.org/10.1016/j.
[8] W. Dimpfel, L. Schombert, A.G. Panossian, Assessing the Quality and Potential Efficacy of Commercial Extracts of Rhodiola rosea L. by Analyzing the Salidroside and Rosavin Content and the Electrophysiological Activity in Hippocampal Long-Term Potentiation, a Synaptic Model of Memory, Front. Pharmacol. 9 (2018) 425. https://doi.org/10.3389/fphar.
[9] M.P. Torrens-Spence, T. Pluskal, F.-S. Li, V. Carballo, J.-K. Weng, Complete Pathway Elucidation and Heterologous Reconstitution of Rhodiola Salidroside Biosynthesis, Molecular Plant 11 (2018) 205–217. https://doi.org/10.1016/j.
[10] L. Jiang, D. Yang, Z. Zhang, L. Xu, Q. Jiang, Y. Tong, L. Zheng, Elucidating the role of Rhodiola rosea L. in sepsis-induced acute lung injury via network pharmacology: emphasis on inflammatory response, oxidative stress, and the PI3K-AKT pathway, Pharmaceutical Biology 62 (2024) 272–284. https://doi.org/10.1080/
[11] S.F. Nabavi, N. Braidy, I.E. Orhan, A. Badiee, M. Daglia, S.M. Nabavi, Rhodiola rosea L. and Alzheimer’s Disease: From Farm to Pharmacy, Phytotherapy Research 30 (2016) 532–539. https://doi.org/10.1002/ptr.
[12] M. Grech-Baran, K. Sykłowska-Baranek, A. Krajewska-Patan, A. Wyrwał, A. Pietrosiuk, Biotransformation of cinnamyl alcohol to rosavins by non-transformed wild type and hairy root cultures of Rhodiola kirilowii, Biotechnol Lett 36 (2014) 649–656. https://doi.org/10.1007/
[13] A.A. Erst, O.V. Kotsupiy, A.S. Erst, A.A. Kuznetsov, Individual Differences in Growth and in Accumulation of Secondary Metabolites in Rhodiola rosea Cultivated in Western Siberia, IJMS 24 (2023) 11244. https://doi.org/10.3390/
[14] E. Ivanova Stojcheva, J.C. Quintela, The Effectiveness of Rhodiola rosea L. Preparations in Alleviating Various Aspects of Life-Stress Symptoms and Stress-Induced Conditions—Encouraging Clinical Evidence, Molecules 27 (2022) 3902. https://doi.org/10.3390/
[15] C. Lelong, L. Ris, O. Sytar, S. Defrère, A. Villers, Rhodiola rosea L. roots powder strongly reduces anxiety and corticosterone level induced by chronic stress in a murine model, J Pharm Health Care Sci 12 (2026) 21. https://doi.org/10.1186/
[16] M. Perfumi, L. Mattioli, Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice, Phytotherapy Research 21 (2007) 37–43. https://doi.org/10.1002/ptr.
[17] Y. Lu, B. Deng, L. Xu, H. Liu, Y. Song, F. Lin, Effects of Rhodiola Rosea Supplementation on Exercise and Sport: A Systematic Review, Front. Nutr. 9 (2022) 856287. https://doi.org/10.3389/fnut.
[18] H. Yun, B. Lu, W. Su, J. Wang, J. Zheng, J. Wang, Z. Wang, Y. Li, Y. Sun, C. Liu, Combined effects of Rhodiola rosea and caffeine supplementation on aerobic endurance and muscle explosiveness: a synergistic approach, Front. Nutr. 11 (2024) 1335950. https://doi.org/10.3389/fnut.
[19] E. Pomari, B. Stefanon, M. Colitti, Effects of Two Different Rhodiola rosea Extracts on Primary Human Visceral Adipocytes, Molecules 20 (2015) 8409–8428. https://doi.org/10.3390/
[20] S. Wang, Y. Feng, L. Zheng, P. He, J. Tan, J. Cai, M. Wu, X. Ye, Rosavin: Research Advances in Extraction and Synthesis, Pharmacological Activities and Therapeutic Effects on Diseases of the Characteristic Active Ingredients of Rhodiola rosea L., Molecules 28 (2023) 7412. https://doi.org/10.3390/
[21] M. Grech-Baran, K. Sykłowska-Baranek, A. Pietrosiuk, Biotechnological approaches to enhance salidroside, rosin and its derivatives production in selected Rhodiola spp. in vitro cultures, Phytochem Rev 14 (2015) 657–674. https://doi.org/10.1007/
[22] M. Kołtun-Jasion, K. Czerwiec, A. Parzonko, A. Bakiera, M. Ożarowski, A.K. Kiss, Comprehensive profiling of Rhodiola rosea roots and corresponding products: phytochemical insights and modulation of neuroinflammation in BV2 microglial cell model, Front. Pharmacol. 16 (2025) 1608767. https://doi.org/10.3389/fphar.
[23] A. Booker, B. Jalil, D. Frommenwiler, E. Reich, L. Zhai, Z. Kulic, M. Heinrich, The authenticity and quality of Rhodiola rosea products, Phytomedicine 23 (2016) 754–762. https://doi.org/10.1016/j.
[24] X. Li, W. Chen, Y. Xu, Z. Liang, H. Hu, S. Wang, Y. Wang, Quality Evaluation of Randomized Controlled Trials of Rhodiola Species: A Systematic Review, Evidence-Based Complementary and Alternative Medicine 2021 (2021) 1–17. https://doi.org/10.1155/2021/
